Middle-East and Africa Liver Cancer Therapeutics Market by Type (Primary, Secondary and Benign Liver growths), by Diagnosis (Ultrasound Scans, Confirmatory Needle Biopsy, Endoscopic Ultrasound, Laparoscopy, CT Scan, PET Scan and Magnetic Resonance Imaging (MRI) Scans), by Therapeutics (Hepatocellular Carcinoma, Cholangio carcinoma, Hepatoblastoma and Targeted Therapy), by End-User (Pediatrics and Adults) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Middle-East and Africa Liver Cancer Therapeutics Market by Type (Primary, Secondary and Benign Liver growths), by Diagnosis (Ultrasound Scans, Confirmatory Needle Biopsy, Endoscopic Ultrasound, Laparoscopy, CT Scan, PET Scan and Magnetic Resonance Imaging (MRI) Scans), by Therapeutics (Hepatocellular Carcinoma, Cholangio carcinoma, Hepatoblastoma and Targeted Therapy), by End-User (Pediatrics and Adults) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 841 | Pages: 139 | December 2016 | Region: Middle East and Africa


The Middle-East and Africa Liver Cancer Therapeutics Market was worth $68.64 million in 2016 and estimated to be growing at a CAGR of 9%, to reach $105.62 million by 2021.

Imaging with ultrasound is the primary diagnostic test as it can identify tumours as small as one centimetre. High perseverance CT scans and divergence MRI scans are used to diagnose and identify stages of these tumours. Every liver cancer is tough to cure. The liver's intricate network of blood vessels and bile ducts makes surgery tough. Most of the treatments ponder on making patients feel better and possibly live longer.

The key driving factors for liver cancer therapeutics market is technological developments, huge investments and funding. Growing demand for safe and cost-effective drugs for the cure of cancer is predicted to enhance the market growth. The harmless cancer screening procedures due to technological innovations offer future growth prospect to industry contributors.

The Middle-East and Africa liver cancer therapeutics market is segmented on the basis of type into primary, secondary and benign liver growths. On the basis of therapeutics market is bifurcated into hepatocellular carcinoma, Cholangio carcinoma, Hepatoblastoma and targeted therapy. By end-use the market is divided amongst pediatrics and adults. Hepatocellular Carcinoma is the largest segment for therapeutics type due to the high prevalence of this type of liver cancer among people.

Based on geography the market is analysed under various regions namely, Middle East and Africa. Middle-East region is estimated to account for highest CAGR in the forecast period while Africa is leading this market.

Some of the key contributors in the industry include Alnylam Pharmaceuticals Inc., ImClone Systems Inc., Onyx Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd., Pfizer Inc., ArQule Inc., Jennerex Biotherapeutics Inc., Celsion Corp., Bayer Schering Pharma AG, 4SC AG, and Bristol-Myers Squibb Company.

1. Introduction                             

              1.1 Market Definition                  

              1.2 Study Deliverables                

              1.3 Base Currency, Base Year and Forecast Periods                       

              1.4 General Study Assumptions              

2. Research Methodology                                       

              2.1 Introduction                           

              2.2 Research Phases                    

                             2.2.1 Secondary Research          

                             2.2.2 Primary Research

                             2.2.3 Econometric Modelling     

                             2.2.4 Expert Validation 

              2.3 Analysis Design                      

              2.4 Study Timeline                       

3. Overview                                   

              3.1 Executive Summary              

              3.2 Key Inferences                       

              3.3 New Developments              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

              4.1 Market Drivers                       

              4.2 Market Restraints                  

              4.3 Key Challenges                       

              4.4 Current Opportunities in the Market                           

5. Market Segmentation                                          

              5.1 By Type                     

                             5.1.1 Primary    

                             5.1.2 Secondary             

                             5.1.3 Benign Liver growths         

              5.2 By Therapeutics                     

                             5.2.1 Hepatocellular Carcinoma

                             5.2.2 Cholangio carcinoma        

                             5.2.3 Hepatoblastoma  

                             5.2.4 Targeted Therapy

              5.3 By End-Users                          

                             5.3.1 Pediatrics

                             5.3.2 Adults      

6. Geographical Analysis                                         

              6.1 Introduction                           

              6.2 Middle-East                            

              6.3 Africa                         

7. Pipeline Product Analysis                                    

              7.1 Overview                                 

              7.2 Pipeline Development Landscape                                 

              7.3 Molecular Targets in the Pipeline                                  

              7.4 Clinical Trials                          

                             7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target    

                             7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target             

                             7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.   

8. Strategic Analysis                                   

              8.1 PESTLE analysis                      

                             8.1.1 Political    

                             8.1.2 Economic

                             8.1.3 Social       

                             8.1.4 Technological       

                             8.1.5 Legal         

                             8.1.6 Environmental     

              8.2 Porter’s Five analysis                          

                             8.2.1 Bargaining Power of Suppliers       

                             8.2.2 Bargaining Power of Consumers   

                             8.2.3 Threat of New Entrants    

                             8.2.4 Threat of Substitute Products and Services             

                             8.2.5 Competitive Rivalry within the Industry     

9. Market Leaders' Analysis                                    

              9.1 Alnylam Pharmaceuticals Inc.                          

                             9.1.1 Overview 

                             9.1.2 Product Analysis  

                             9.1.3 Strategic Evaluation and Operations          

                             9.1.4 Financial analysis 

                             9.1.5 Legal issues           

                             9.1.6 Recent Developments       

                             9.1.7 SWOT analysis      

                             9.1.8 Analyst View         

              9.2 ImClone Systems Inc.                          

              9.3 Onyx Pharmaceuticals Inc.                 

              9.4 F. Hoffmann-La Roche Ltd.                

              9.5 Pfizer Inc.                  

              9.6 ArQule Inc.               

              9.7 Jennerex Biotherapeutics Inc.                         

              9.8 Celsion Corp.                          

              9.9 Bayer Schering Pharma AG                

              9.10 4SC AG                    

              9.11 Bristol-Myers Squibb Company                    

10. Competitive Landscape                                     

              10.1 Market share analysis                      

              10.2 Merger and Acquisition Analysis                  

              10.3 Agreements, collaborations and Joint Ventures                    

              10.4 New Product Launches                     

11. Expert Opinions                                   

              11.1 Market Outlook                   

              11.2 Investment Opportunities               

Appendix                                       

              a) List of Tables              

              b) List of Figures                           

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Liver Cancer Diagnostics and Therapeutics Market By Region, From 2016-2021 (USD Million)
  2. Middle East & Africa Liver Cancer Diagnostics and Therapeutics Market By Type, From 2016-2021 (USD Million)
  3. Middle East & Africa Primary Market By Region, From 2016-2021 (USD Million)
  4. Middle East & Africa Secondary Market By Region, From 2016-2021 (USD Million)
  5. Middle East & Africa Benign Liver growths Market By Region, From 2016-2021 (USD Million)
  6. Middle East & Africa Liver Cancer Diagnostics and Therapeutics Market By Therapeutics, From 2016-2021 (USD Million)
  7. Middle East & Africa Hepatocellular Carcinoma Market By Region, From 2016-2021 (USD Million)
  8. Middle East & Africa Cholangio carcinoma Market By Region, From 2016-2021 (USD Million)
  9. Middle East & Africa Hepatoblastoma Market By Region, From 2016-2021 (USD Million)
  10. Middle East & Africa Targeted Therapy Market By Region, From 2016-2021 (USD Million)
  11. Middle East & Africa Liver Cancer Diagnostics and Therapeutics Market By End-Users, From 2016-2021 (USD Million)
  12. Middle East & Africa Pediatrics Market By Region, From 2016-2021 (USD Million)
  13. Middle East & Africa Adults Market By Region, From 2016-2021 (USD Million)
  14. Middle East Liver Cancer Diagnostics and Therapeutics Market By Type, From 2016-2021 (USD Million)
  15. Middle East Liver Cancer Diagnostics and Therapeutics Market By Therapeutics, From 2016-2021 (USD Million)
  16. Middle East Liver Cancer Diagnostics and Therapeutics Market By End-Users, From 2016-2021 (USD Million)
  17. Africa Liver Cancer Diagnostics and Therapeutics Market By Type, From 2016-2021 (USD Million)
  18. Africa Liver Cancer Diagnostics and Therapeutics Market By Therapeutics, From 2016-2021 (USD Million)
  19. Africa Liver Cancer Diagnostics and Therapeutics Market By End-Users, From 2016-2021 (USD Million)
Middle East And Africa Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiol...
Latin America Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mo...
Asia Pacific Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Moo...
Europe Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stab...
North America Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mo...
Psychiatry Therapies Market By Type (Social Psychology, Abnormal Psychology, Biological Psychology And Other Types), By Type Of Medication (Antidepressants, Antipsychotics, Depressants, Anxiolytics, Mood Stabilisers...
Middle East and Africa Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Servic...
Latin America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Asia-Pacific Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskil...
Europe Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unskilled Ca...
North America Home Healthcare Market by Product (Testing, Screening, & Monitoring Products, Therapeutic Products, Mobility Care Products) by Service (Rehabilitation Therapy Services, Infusion Therapy Services, Unski...
Home Healthcare Market by Product (Mobility Care Products ,Screening, & Monitoring Products, Testing, Therapeutic Products) by Service (Infusion Therapy Services, Rehabilitation Therapy Services, Unskilled Care Serv...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.